Profil
Thomas de Kempeneer currently works at IQVIA MedTech NV, as Director and Healthy Holding NV, as Director from 2020.
Mr. de Kempeneer also formerly worked at Korys Management NV, as Investment Director from 2019 to 2022, MyOptique Group Ltd., as Director from 2014 to 2016, Planet-eco NV, as Director, and KBC Private Equity NV, as Investment Manager from 2010 to 2013.
Mr. de Kempeneer received his graduate degree in 2006 from Vlerick Leuven Gent Management School and undergraduate degree in 2005 from Ghent University.
Postes actifs de Thomas de Kempeneer
| Sociétés | Poste | Début |
|---|---|---|
IQVIA MedTech NV
IQVIA MedTech NV BiotechnologyHealth Technology Provides contract research services | Directeur/Membre du Conseil | - |
Healthy Holding SA
Healthy Holding SA Medical DistributorsDistribution Services Provides health care services | Directeur/Membre du Conseil | 27/01/2020 |
Anciens postes connus de Thomas de Kempeneer
| Sociétés | Poste | Fin |
|---|---|---|
Korys Management NV
Korys Management NV Investment ManagersFinance Korys invests in companies located in Belgium. The firm focuses on conscious consumer, energy transition and healthy living sectors. It participates in buyout and early stage transactions with an investment size of EUR 5 - 15 million. The firm also makes investment in private equity funds. | Private Equity Investor | 01/03/2022 |
MyOptique Group Ltd.
MyOptique Group Ltd. Specialty StoresRetail Trade Operates as an online prescription eyewear store | Directeur/Membre du Conseil | 02/09/2016 |
KBC Private Equity NV
KBC Private Equity NV Investment ManagersFinance KBC Private Equity is an active, long-term manager which typically invests between €2 million and €50 million in medium-sized unlisted companies primarily in Belgium, Central and Eastern Europe. The firm targets performing businesses in diverse sectors which usually demonstrate a positive EBITDA of at least €1.5 million, focusing on companies which have built up a leading position in a specific sector and which have identified growth opportunities. Specific criteria apply for investments in the biotech industry. The firm takes both majority and minority interests in companies, partnering with the other shareholders and investee company management. In addition to providing equity and/or mezzanine financing, they aim to create value in areas where they are skilled, without participating in the day-to-day operational policy of the investee company. KBC Private Equity generally seeks a seat on the Board of Directors. The firm aims to contribute to investee companies by evaluating their internal and external growth opportunities, optimizing their financial structure, introducing new customer and supplier relationships, improving reporting systems and sharing specific industry knowledge. Their typical holding period is five to seven years for most of their investment projects. | Analyste en capital-investissement | 01/01/2013 |
Planet-eco NV
Planet-eco NV Wholesale DistributorsDistribution Services Engages in retail of solar panels, sun boilers and heat exchange pumps | Directeur/Membre du Conseil | - |
Formation de Thomas de Kempeneer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Korys Management NV
Korys Management NV Investment ManagersFinance Korys invests in companies located in Belgium. The firm focuses on conscious consumer, energy transition and healthy living sectors. It participates in buyout and early stage transactions with an investment size of EUR 5 - 15 million. The firm also makes investment in private equity funds. | Finance |
Ghent University
Ghent University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KBC Private Equity NV
KBC Private Equity NV Investment ManagersFinance KBC Private Equity is an active, long-term manager which typically invests between €2 million and €50 million in medium-sized unlisted companies primarily in Belgium, Central and Eastern Europe. The firm targets performing businesses in diverse sectors which usually demonstrate a positive EBITDA of at least €1.5 million, focusing on companies which have built up a leading position in a specific sector and which have identified growth opportunities. Specific criteria apply for investments in the biotech industry. The firm takes both majority and minority interests in companies, partnering with the other shareholders and investee company management. In addition to providing equity and/or mezzanine financing, they aim to create value in areas where they are skilled, without participating in the day-to-day operational policy of the investee company. KBC Private Equity generally seeks a seat on the Board of Directors. The firm aims to contribute to investee companies by evaluating their internal and external growth opportunities, optimizing their financial structure, introducing new customer and supplier relationships, improving reporting systems and sharing specific industry knowledge. Their typical holding period is five to seven years for most of their investment projects. | Finance |
Vlerick Leuven Gent Management School
Vlerick Leuven Gent Management School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MyOptique Group Ltd.
MyOptique Group Ltd. Specialty StoresRetail Trade Operates as an online prescription eyewear store | Retail Trade |
Planet-eco NV
Planet-eco NV Wholesale DistributorsDistribution Services Engages in retail of solar panels, sun boilers and heat exchange pumps | Distribution Services |
IQVIA MedTech NV
IQVIA MedTech NV BiotechnologyHealth Technology Provides contract research services | Health Technology |
Healthy Holding SA
Healthy Holding SA Medical DistributorsDistribution Services Provides health care services | Distribution Services |
















